Hyperstat Side Effects
Generic name: diazoxide
Note: This document contains side effect information about diazoxide. Some of the dosage forms listed on this page may not apply to the brand name Hyperstat.
Some side effects of Hyperstat may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to diazoxide: oral capsule, oral suspension
Along with its needed effects, diazoxide (the active ingredient contained in Hyperstat) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Stop taking diazoxide and get emergency help immediately if any of the following effects occur:Rare
- Chest pain caused by exercise or activity
- numbness of the hands
- shortness of breath (unexplained)
Check with your doctor as soon as possible if any of the following side effects occur while taking diazoxide:More common
- Decreased urination
- swelling of feet or lower legs
- weight gain (rapid)
- Fast heartbeat
- skin rash
- stiffness of arms or legs
- trembling and shaking of hands and fingers
- unusual bleeding or bruising
Some side effects of diazoxide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:Less common
- Changes in ability to taste
- increased hair growth on forehead, back, arms, and legs
- loss of appetite
- nausea and vomiting
- stomach pain
This medicine may cause a temporary increase in hair growth in some people when it is used for a long time. After treatment with diazoxide has ended, normal hair growth should return.
For Healthcare Professionals
Applies to diazoxide: compounding powder, injectable solution, oral capsule, oral suspension
The most common reactions reported following diazoxide (the active ingredient contained in Hyperstat) administration include hypotension (7%), nausea and vomiting (4%), dizziness and weakness (2%).
Cardiovascular effects including sodium and water retention following repeated injections, hypotension, shock, myocardial ischemia, myocardial and cerebral infarction, angina, atrial and ventricular arrhythmias, marked electrocardiographic changes, optic nerve infarction, supraventricular tachycardia and palpitation, bradycardia, and chest discomfort have been reported.
Angina with myocardial and cerebral infarction have been associated with the use of a 300 mg intravenous dose of diazoxide.
One case of optic nerve infarction was reported following a single 300 mg bolus dose of diazoxide, as a result of a sudden reduction in diastolic pressure.
Results from one prospective trial conducted in patients with severe hypertension and coronary artery disease showed a 50% incidence of ischemic changes in the electrocardiogram following single 300 mg bolus injections of diazoxide.
Nervous system affects reported following diazoxide (the active ingredient contained in Hyperstat) administration include cerebral ischemia, convulsions, paralysis, confusion, numbness of the hands, orthostatic hypotension, sweating, flushing, generalized or localized sensations of warmth, headache, dizziness, lightheadedness, sleepiness, lethargy, somnolence, drowsiness, euphoria, tinnitus, momentary loss of hearing, weakness and anxiety.
Gastrointestinal side effects have been rarely reported and include acute pancreatitis, nausea, vomiting, abdominal discomfort, anorexia, alteration in taste, parotid swelling, salivation, dry mouth, lacrimation, ileus, constipation and diarrhea.
Metabolic effects including hyperglycemia have been reported in diabetic and nondiabetic patients, especially after repeated injections. Transient retention of nitrogenous wastes has also been reported.
Respiratory effects including dyspnea, cough and choking sensation have been reported.
Hypersensitivity reactions characterized by rash, leukopenia, fever and papilledema induced by plasma volume expansion secondary to the administration of diazoxide (the active ingredient contained in Hyperstat) have been reported.
Other effects including warmth or pain along the injected vein, cellulitis and/or phlebitis at the injection site of extravasation, back pain, increased nocturia, malaise, blurred vision, hirsutism, and decreased libido have been reported.
More Hyperstat resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.